ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 319 out of 3647

$960K Total Retail Price of All Prescriptions

Rank: 253 out of 3647

758 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 758 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 758 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 13,556 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 859 706 1 1
HYDROCODONE-ACETAMINOPHEN 711 424 S3 2 12
AMLODIPINE BESYLATE 557 466 3 2
CARVEDILOL 538 457 4 20
LISINOPRIL 481 396 5 4
PRAVASTATIN SODIUM 438 373 6 16
METFORMIN HCL 381 294 7 6
OMEPRAZOLE 381 282 7 3
LEVOTHYROXINE SODIUM 358 292 9 5
BENAZEPRIL HCL 355 304 10 71
GABAPENTIN 343 219 11 17
METOPROLOL TARTRATE 319 256 12 7
FUROSEMIDE 294 239 13 8
GLIPIZIDE 291 239 14 41
BENAZEPRIL-HYDROCHLOROTHIAZIDE 288 229 15 270
CITALOPRAM HBR 282 213 16 25
LOSARTAN POTASSIUM 278 223 17 11
LOSARTAN-HYDROCHLOROTHIAZIDE 219 214 18 48
ALPRAZOLAM 212 157 19 31
HYDROCHLOROTHIAZIDE 194 173 20 9
FENOFIBRATE 188 125 21 50
METOPROLOL SUCCINATE 187 175 22 18
WARFARIN SODIUM 181 151 23 15
ATORVASTATIN CALCIUM 176 129 24 13
SPIRONOLACTONE 173 152 25 77
ZOLPIDEM TARTRATE 168 117 26 14
DIGOXIN 166 138 27 51
POTASSIUM CHLORIDE 150 114 28 24
PREDNISONE 149 137 29 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 129 30 36
ALLOPURINOL 142 132 31 37
FINASTERIDE 137 136 32 66
TRAMADOL HCL 135 75 33 22
ATENOLOL 126 108 34 10
GLIMEPIRIDE 126 103 34 45
TAMSULOSIN HCL 126 121 34 28
ALENDRONATE SODIUM 121 108 37 23
BUPROPION HCL SR 119 84 38 249
TERAZOSIN HCL 110 109 39 103
AMITRIPTYLINE HCL 109 66 R 40 105
LOVASTATIN 108 98 41 21
SPIRONOLACTONE-HCTZ 107 71 42 303
HYDRALAZINE HCL 104 79 43 81
SYMBICORT 97 70 44 153
SERTRALINE HCL 96 60 45 27
DICLOFENAC SODIUM 96 78 45 86
DONEPEZIL HCL 93 83 47 30
NEXIUM 93 89 47 44
CRESTOR 90 59 49 19
RANITIDINE HCL 88 64 50 29
ADVAIR DISKUS 87 61 51 52
AMOX TR-POTASSIUM CLAVULANATE 84 69 52 118
PROAIR HFA 84 47 52 62
AZITHROMYCIN 83 61 54 34
TRAZODONE HCL 82 29 55 64
FELODIPINE ER 81 75 56 186
TORSEMIDE 80 66 57 215
MELOXICAM 80 70 57 33
FLUTICASONE PROPIONATE 80 60 57 32
JANUVIA 75 50 60 72
INSULIN SYRINGE 74 55 61 76
LANTUS 70 45 62 59
GEMFIBROZIL 68 51 63 82
VENTOLIN HFA 67 43 64 88
OXYCODONE HCL-ACETAMINOPHEN 67 37 S2 64 104
SYNTHROID 64 50 66 42
BACLOFEN 63 37 67 97
NOVOLIN N 62 56 68 320
OXYCODONE HCL 61 19 S2 69 75
METFORMIN HCL ER 61 38 69 92
TEMAZEPAM 60 46 71 47
PLAVIX 58 54 72 39
DOXAZOSIN MESYLATE 57 57 73 57
METHYLPREDNISOLONE 57 40 73 78
TRIAMTERENE-HCTZ 54 44 75 58
PEN NEEDLE 54 47 75 166
CIPROFLOXACIN HCL 52 43 77 53
LANTUS SOLOSTAR 51 50 78 124
VERAPAMIL ER 51 39 78 99
ZETIA 50 40 80 96
CYCLOBENZAPRINE HCL 50 27 R 80 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.